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Most of the effects of the signalling molecule nitric oxide
(NO) are mediated by the stimulation of the NO-sensitive
guanylyl cyclase (GC) and the subsequent increase in
cGMP formation. The enzyme contains a prosthetic heme
group which mediates NO stimulation. In addition to the
physiological activator NO, NO-sensitisers like the sub-
stance YC-1 sensitise the enzyme towards NO and may
therefore have important pharmacological implications.
Two isoforms of NO-sensitive GC have been identified to
date that share regulatory properties but differ in the sub-
cellular localization; the more ubiquitously expressed
α1β1 heterodimer and the α2β1 isoform mainly expressed
in brain. Knock-out mice in which either one the GC sub-
units is deleted will provide information about the func-
tional roles of GC and the isoforms.
In intact cells, NO-induced cGMP signalling not only
depends on cGMP formation but is also critically deter-
mined by the activity of the enzyme responsible for cGMP
degradation i.e. phosphodiesterase 5 (PDE5). Recently,
direct activation of PDE5 by cGMP was demonstrated
which is limiting the cGMP increase and therefore is func-
tioning as a negative feedback. As the cGMP-induced
PDE5 activation turned out to be sustained, in the range
of hours, it is probably responsible for the NO-induced
desensitisation observed within NO/cGMP signalling.
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